Tonix Pharm Holdings (TNXP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 43,870 | 49,547 | 8,202 | 7,420 | 68 |
| TOTAL | $44,816 | $50,101 | $8,631 | $7,466 | $114 |
| Non-Current Assets | |||||
| PPE Net | 71 | 43 | 45 | 43 | 39 |
| Other Non-Current Assets | 178 | 60 | 60 | 60 | 161 |
| TOTAL | $249 | $103 | $105 | $103 | $200 |
| Total Assets | $45,065 | $50,204 | $8,736 | $7,570 | $314 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 280 | 280 | 280 | 280 | 200 |
| Accounts payable and accrued liabilities | 1,518 | 1,399 | 765 | 986 | 1,461 |
| Accrued Expenses | 573 | 596 | 1,166 | 854 | 602 |
| TOTAL | $2,371 | $2,275 | $2,211 | $2,120 | $2,263 |
| Non-Current Liabilities | |||||
| TOTAL | $30 | $6 | $13 | $14 | $15 |
| Total Liabilities | $2,401 | $2,281 | $2,224 | $2,133 | $2,278 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 10,590 | 9,929 | 9,899 | 4,877 | 4,877 |
| Common Shares | 10 | 10 | 6 | 5 | 2 |
| Retained earnings | -37,936 | -31,892 | -26,728 | -23,021 | -19,931 |
| Other shareholders' equity | 4 | 1 | -1 | 0 | 0 |
| TOTAL | $42,664 | $47,923 | $6,512 | $5,436 | $-1,964 |
| Total Liabilities And Equity | $45,065 | $50,204 | $8,736 | $7,569 | $315 |